Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for LifeStance Health (LFST) over the last 6 years, with Q2 2025 value amounting to -$0.01.

  • LifeStance Health's EPS (Basic) rose 8333.33% to -$0.01 in Q2 2025 from the same period last year, while for Sep 2025 it was -$0.03, marking a year-over-year increase of 8846.15%. This contributed to the annual value of -$0.15 for FY2024, which is 7029.3% up from last year.
  • Per LifeStance Health's latest filing, its EPS (Basic) stood at -$0.01 for Q2 2025, which was up 8333.33% from -$0.02 recorded in Q4 2024.
  • LifeStance Health's EPS (Basic)'s 5-year high stood at -$0.01 during Q2 2025, with a 5-year trough of -$350.77 in Q3 2021.
  • For the 5-year period, LifeStance Health's EPS (Basic) averaged around -$20.75, with its median value being -$0.13 (2022).
  • As far as peak fluctuations go, LifeStance Health's EPS (Basic) tumbled by 350759087.4% in 2021, and later surged by 9996.86% in 2022.
  • Over the past 5 years, LifeStance Health's EPS (Basic) (Quarter) stood at -$0.32 in 2021, then skyrocketed by 59.38% to -$0.13 in 2022, then rose by 7.69% to -$0.12 in 2023, then surged by 84.37% to -$0.02 in 2024, then surged by 46.69% to -$0.01 in 2025.
  • Its last three reported values are -$0.01 in Q2 2025, -$0.02 for Q4 2024, and -$0.02 during Q3 2024.